Glucagonoma - A tumour disease with multiple clinical manifestations;Glukagonom: Tumörsjukdom med mångfasetterad klinisk bild

Lakartidningen

Volumn 93, Issue 35, 1996, Pages 2935-2939

  Andersson, Karin ^a   Wängberg, Bo ^b   Tisell, Lars Erik ^b   Nilsson, Ola ^b   Fjälling, Martha ^b   Forssell Aronsson, Eva ^b   Ahrén, Bo ^c   Ahlman, Håkan ^b  

^a Borås Lasarett ^*

^b SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

^c KAROLINSKA INSTITUTE   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; DIFFERENTIAL DIAGNOSIS; FEMALE; GLUCAGONOMA; HUMAN; MALE; MIDDLE AGED; PANCREAS TUMOR; PATHOLOGY; PROGNOSIS; SKIN;

ADULT; DIAGNOSIS, DIFFERENTIAL; FEMALE; GLUCAGONOMA; HUMANS; MALE; MIDDLE AGED; PANCREATIC NEOPLASMS; PROGNOSIS; SKIN;

EID: 0030604806     PISSN: 00237205     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Becker SW, Kahn D, Rothman S. Cutaneous manifestations of internal malignant tumors. Archives of Dermatology and Syphitology 1942; 45: 1068-80.
2. Me Gavran MH, Unger RH, Recant L, Polk HC, Kilo C, Levin ME. A glucagon-secreting alpha-cell carcinoma of the pancreas. N Engl J Med 1966; 274: 1408-13.
3. Mallinson CN, Bloom SR, Warin AP, Salman PR, Cox B. A glucagonoma syndrome. Lancet 1974; 2: 1-5.
4. Wilkinson DS. Necrolytic migratory erythema with carcinoma of the pancreas. Transactions of the St Johns Hospital Dermatological Society 1973; 59: 244.
5. Higgins GA, Recant L, Fischman AE. The glucagonoma syndrome: Surgically curable diabetes. Am J Surg 1979; 137: 142-8.
6. Edney JA, Hofmann S, Thompson JS. Glucagonoma syndrome is an underdiagnosed clinical entity. Am J Surg 1990; 160: 625-9.
7. Stacpoole PW. The glucagonoma syndrome: clinical features, diagnosis and treatment. Endocr Rev 1981; 2: 347-63.
8. Miller SJ. Nutritional deficiency and the skin. J Am Acad Dermatol 1989; 21:1-30.
9. Bloom SR, Polak JM. Glucagonoma syndrome. Am J Med 1987; 82: 25-36.
10. Wynick D, Williams SJ, Bloom SR. Symtomatic secondary hormone syndromes in patients with established malignant endocrine tumors. N Engl J Med 1988; 319: 605-7.
11. Bordi C, DeVita O, Pilato FP, Carfagna G, D'Adda T, Missote G et al. Multiple islet cell tumors with predominance of glucagon producing cells and ulcer disease. Am J Clin Pathol 1987; 88: 153-61.
12. Maton PN, Gardner JD, Jensen RT. Use of long-acting somatostatin analogue SMS 201-995 in patients with pancreatic islet cell tumors. Dig Dis Sci 1989; 34: 28-39S.
13. Anthony LB, Sharp SC, May ME. Case report: diabetic ketoacidosis in a patient with glucagonoma. Am J Med Sci 1995; 309: 326-7.
14. Boden G. Insulinoma and glukagonoma. Semin Oncol 1987; 14: 253-62.
15. Welbourn RB. Islet cell tumours-pancreatic apodumas. In: Thompson NW, Vinik AI, eds. Endocrine Surgery Update. New York: Grune & Stratton, 1983: 173-93.
16. Thompson GB, van Heerden JA, Grant CS, Carney A, Ilstrup D. Islet cell carcinomas of the pancreas. Surgery 1988; 104: 1011-7.
17. Venkatesh S, Ordonez N, Ajani JH, Schultz PN, Hickey RC, Johnston DA et al. Islet cell carcinoma of the pancreas. Cancer 1990; 65: 354-7.
18. Howard TJ, Stabile BE, Zinner MJ, Chang S, Bhargavan BC, Passaro E Jr. Anatomic distribution of pancreatic endocrine tumors. Am J Surg 1990; 159: 258-64.
19. Rossi P, Allison DJ, Bezzi M, Kennedy A, Maccinoni F, Wynick D et al. Endocrine tumors of the pancreas. Radiol Clin North Am 1989; 27: 129-61.
20. Moertel C, Johnson C, McKusick M, Martin J, Nagarney D, Kvols L et al. The management of patients with advanced carcinoid tumors and islet cell carcinomas. Ann Intern Med 1994;120: 302-9.